Intuitive Surgical Hits 52-Week Low as Procedure Growth Concerns Mount
Read source articleWhat happened
Intuitive Surgical's stock fell to a 52-week low after the company reaffirmed its 2026 da Vinci procedure growth outlook but acknowledged slowing U.S. procedure trends and insurance-related headwinds that rattled investors. The selloff validates the concerns outlined in DeepValue's recent analysis, which flagged that nearly all U.S. placement growth was driven by trade-ins and that U.S. utilization growth at 12% may not justify the stock's premium multiple. While Q2 2026 revenue rose 19% and procedures grew 16% globally, the market is focusing on the deteriorating quality of growth, with trade-ins rising to 144 from 83 a year ago and China remaining a persistent drag. The company's installed base of 11,710 da Vinci systems and 85% recurring revenue provide a resilient foundation, but valuation at 48x earnings leaves little room for disappointment. The base case of $410 per share offers limited upside from current levels, and the bear case of $320 becomes more probable if U.S. procedure growth slips below 12% and trade-ins remain elevated.
Implication
Intuitive Surgical remains a high-quality business with a durable moat, but the current valuation at 48x earnings prices in perfect execution. Given the slowing U.S. growth and reliance on trade-ins, investors should wait for a clearer signal that demand is broadening beyond the da Vinci 5 upgrade cycle. The 3-6 month re-assessment window is appropriate; use the $360 attractive entry point as a potential re-entry zone if the stock continues to drift lower.
Thesis delta
The news confirms the report's bearish skew: U.S. procedure trends are decelerating and trade-ins dominate placement growth, increasing the likelihood of the bear case. The earlier base-case assumption that international utilization would offset U.S. softness is now under pressure as the market focuses on U.S. weakness. The thesis shifts from 'wait for proof of broadening growth' to 'heightened risk of a growth-quality downgrade.'
Confidence
Moderate